Novartis Ag (NVSEF) Income towards Parent Company (2009 - 2025)

Novartis Ag (NVSEF) has 15 years of Income towards Parent Company data on file, last reported at $42.0 billion in Q2 2025.

• Quarterly Income towards Parent Company rose 0.6% year-over-year to $42.0 billion in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $42.0 billion (up 0.6% YoY) and the FY2025 annual result came in at $14.0 billion, down 68.25% from the prior year.
• Income towards Parent Company slipped to $42.0 billion in Q2 2025 per NVSEF's latest filing, from $44.0 billion in the prior quarter.
• The five-year high for Income towards Parent Company was $34001.4 billion in Q1 2022, with the low at $144.0 million in Q1 2023.
• Average Income towards Parent Company over 5 years is $2298.3 billion, with a median of $44.0 billion recorded in 2024.
• Year-over-year, Income towards Parent Company surged 2569920.56% in 2022 and slumped 100.0% in 2023.
• Novartis Ag's Income towards Parent Company stood at $67.7 billion in 2021, then decreased by 12.29% to $59.3 billion in 2022, then decreased by 21.36% to $46.7 billion in 2023, then declined by 5.62% to $44.0 billion in 2024, then declined by 4.68% to $42.0 billion in 2025.
• Business Quant data shows NVSEF's Income towards Parent Company at $42.0 billion in Q2 2025, $44.0 billion in Q4 2024, and $41.7 billion in Q2 2024.